nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A1—Cytarabine—lymphatic system cancer	0.18	0.241	CbGbCtD
Clonidine—SLC22A3—Vincristine—lymphatic system cancer	0.166	0.222	CbGbCtD
Clonidine—CYP1A2—Carmustine—lymphatic system cancer	0.0923	0.124	CbGbCtD
Clonidine—CYP3A5—Teniposide—lymphatic system cancer	0.0834	0.112	CbGbCtD
Clonidine—CYP3A5—Vincristine—lymphatic system cancer	0.0401	0.0539	CbGbCtD
Clonidine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0379	0.0509	CbGbCtD
Clonidine—CYP3A4—Cytarabine—lymphatic system cancer	0.033	0.0443	CbGbCtD
Clonidine—CYP3A4—Teniposide—lymphatic system cancer	0.0325	0.0436	CbGbCtD
Clonidine—ABCB1—Vincristine—lymphatic system cancer	0.0261	0.035	CbGbCtD
Clonidine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0227	0.0305	CbGbCtD
Clonidine—ABCB1—Methotrexate—lymphatic system cancer	0.0158	0.0212	CbGbCtD
Clonidine—CYP3A4—Vincristine—lymphatic system cancer	0.0156	0.021	CbGbCtD
Clonidine—NISCH—Podofilox—Teniposide—lymphatic system cancer	0.00589	0.71	CbGdCrCtD
Clonidine—NISCH—Vinblastine—Vincristine—lymphatic system cancer	0.00241	0.29	CbGdCrCtD
Clonidine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000666	0.0027	CcSEcCtD
Clonidine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000664	0.00269	CcSEcCtD
Clonidine—Sweating—Vincristine—lymphatic system cancer	0.000656	0.00266	CcSEcCtD
Clonidine—Nausea—Mechlorethamine—lymphatic system cancer	0.000655	0.00265	CcSEcCtD
Clonidine—Alopecia—Bleomycin—lymphatic system cancer	0.000651	0.00264	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000651	0.00264	CcSEcCtD
Clonidine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000647	0.00263	CcSEcCtD
Clonidine—Urticaria—Teniposide—lymphatic system cancer	0.000645	0.00262	CcSEcCtD
Clonidine—Body temperature increased—Teniposide—lymphatic system cancer	0.000642	0.0026	CcSEcCtD
Clonidine—Abdominal pain—Teniposide—lymphatic system cancer	0.000642	0.0026	CcSEcCtD
Clonidine—Erythema—Bleomycin—lymphatic system cancer	0.000641	0.0026	CcSEcCtD
Clonidine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000641	0.0026	CcSEcCtD
Clonidine—Hallucination—Carmustine—lymphatic system cancer	0.00064	0.00259	CcSEcCtD
Clonidine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00064	0.00259	CcSEcCtD
Clonidine—Sweating—Mitoxantrone—lymphatic system cancer	0.000639	0.00259	CcSEcCtD
Clonidine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000637	0.00258	CcSEcCtD
Clonidine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000621	0.00252	CcSEcCtD
Clonidine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000616	0.0025	CcSEcCtD
Clonidine—Fatigue—Fludarabine—lymphatic system cancer	0.000616	0.0025	CcSEcCtD
Clonidine—Hallucination—Vincristine—lymphatic system cancer	0.000611	0.00248	CcSEcCtD
Clonidine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000611	0.00248	CcSEcCtD
Clonidine—Pain—Fludarabine—lymphatic system cancer	0.000611	0.00248	CcSEcCtD
Clonidine—Constipation—Fludarabine—lymphatic system cancer	0.000611	0.00248	CcSEcCtD
Clonidine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000609	0.00247	CcSEcCtD
Clonidine—Respiratory failure—Methotrexate—lymphatic system cancer	0.000604	0.00245	CcSEcCtD
Clonidine—Eye disorder—Carmustine—lymphatic system cancer	0.000601	0.00244	CcSEcCtD
Clonidine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000599	0.00243	CcSEcCtD
Clonidine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000599	0.00243	CcSEcCtD
Clonidine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000598	0.00242	CcSEcCtD
Clonidine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000595	0.00241	CcSEcCtD
Clonidine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000588	0.00239	CcSEcCtD
Clonidine—Asthenia—Teniposide—lymphatic system cancer	0.000583	0.00236	CcSEcCtD
Clonidine—Malaise—Bleomycin—lymphatic system cancer	0.000578	0.00235	CcSEcCtD
Clonidine—Pruritus—Teniposide—lymphatic system cancer	0.000575	0.00233	CcSEcCtD
Clonidine—Arrhythmia—Carmustine—lymphatic system cancer	0.000575	0.00233	CcSEcCtD
Clonidine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00057	0.00231	CcSEcCtD
Clonidine—Alopecia—Carmustine—lymphatic system cancer	0.000568	0.0023	CcSEcCtD
Clonidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000564	0.00229	CcSEcCtD
Clonidine—Mental disorder—Carmustine—lymphatic system cancer	0.000564	0.00228	CcSEcCtD
Clonidine—Erythema—Carmustine—lymphatic system cancer	0.00056	0.00227	CcSEcCtD
Clonidine—Cough—Bleomycin—lymphatic system cancer	0.00056	0.00227	CcSEcCtD
Clonidine—Angiopathy—Vincristine—lymphatic system cancer	0.000557	0.00226	CcSEcCtD
Clonidine—Diarrhoea—Teniposide—lymphatic system cancer	0.000556	0.00225	CcSEcCtD
Clonidine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000553	0.00224	CcSEcCtD
Clonidine—Chest pain—Bleomycin—lymphatic system cancer	0.000546	0.00221	CcSEcCtD
Clonidine—Alopecia—Vincristine—lymphatic system cancer	0.000543	0.0022	CcSEcCtD
Clonidine—Discomfort—Bleomycin—lymphatic system cancer	0.00054	0.00219	CcSEcCtD
Clonidine—Mental disorder—Vincristine—lymphatic system cancer	0.000538	0.00218	CcSEcCtD
Clonidine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000534	0.00217	CcSEcCtD
Clonidine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000531	0.00215	CcSEcCtD
Clonidine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000528	0.00214	CcSEcCtD
Clonidine—Confusional state—Bleomycin—lymphatic system cancer	0.000528	0.00214	CcSEcCtD
Clonidine—Vision blurred—Carmustine—lymphatic system cancer	0.000528	0.00214	CcSEcCtD
Clonidine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000526	0.00213	CcSEcCtD
Clonidine—Tremor—Carmustine—lymphatic system cancer	0.000525	0.00213	CcSEcCtD
Clonidine—Oedema—Bleomycin—lymphatic system cancer	0.000524	0.00212	CcSEcCtD
Clonidine—Erythema—Mitoxantrone—lymphatic system cancer	0.000521	0.00211	CcSEcCtD
Clonidine—Infection—Bleomycin—lymphatic system cancer	0.00052	0.00211	CcSEcCtD
Clonidine—Vomiting—Teniposide—lymphatic system cancer	0.000517	0.00209	CcSEcCtD
Clonidine—Agitation—Carmustine—lymphatic system cancer	0.000515	0.00209	CcSEcCtD
Clonidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000513	0.00208	CcSEcCtD
Clonidine—Asthenia—Fludarabine—lymphatic system cancer	0.000512	0.00208	CcSEcCtD
Clonidine—Rash—Teniposide—lymphatic system cancer	0.000512	0.00208	CcSEcCtD
Clonidine—Dermatitis—Teniposide—lymphatic system cancer	0.000512	0.00207	CcSEcCtD
Clonidine—Headache—Teniposide—lymphatic system cancer	0.000509	0.00206	CcSEcCtD
Clonidine—Pruritus—Fludarabine—lymphatic system cancer	0.000505	0.00205	CcSEcCtD
Clonidine—Anorexia—Bleomycin—lymphatic system cancer	0.000499	0.00202	CcSEcCtD
Clonidine—Agitation—Vincristine—lymphatic system cancer	0.000491	0.00199	CcSEcCtD
Clonidine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000491	0.00199	CcSEcCtD
Clonidine—Hypotension—Bleomycin—lymphatic system cancer	0.000489	0.00198	CcSEcCtD
Clonidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000489	0.00198	CcSEcCtD
Clonidine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000483	0.00196	CcSEcCtD
Clonidine—Nausea—Teniposide—lymphatic system cancer	0.000483	0.00196	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000477	0.00193	CcSEcCtD
Clonidine—Chest pain—Carmustine—lymphatic system cancer	0.000477	0.00193	CcSEcCtD
Clonidine—Anxiety—Carmustine—lymphatic system cancer	0.000475	0.00193	CcSEcCtD
Clonidine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00047	0.00191	CcSEcCtD
Clonidine—Malaise—Mitoxantrone—lymphatic system cancer	0.000469	0.0019	CcSEcCtD
Clonidine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000467	0.00189	CcSEcCtD
Clonidine—Confusional state—Carmustine—lymphatic system cancer	0.000461	0.00187	CcSEcCtD
Clonidine—Oedema—Carmustine—lymphatic system cancer	0.000457	0.00185	CcSEcCtD
Clonidine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000455	0.00185	CcSEcCtD
Clonidine—Cough—Mitoxantrone—lymphatic system cancer	0.000454	0.00184	CcSEcCtD
Clonidine—Infection—Carmustine—lymphatic system cancer	0.000454	0.00184	CcSEcCtD
Clonidine—Vomiting—Fludarabine—lymphatic system cancer	0.000454	0.00184	CcSEcCtD
Clonidine—Rash—Fludarabine—lymphatic system cancer	0.00045	0.00183	CcSEcCtD
Clonidine—Dermatitis—Fludarabine—lymphatic system cancer	0.00045	0.00182	CcSEcCtD
Clonidine—Pain—Bleomycin—lymphatic system cancer	0.000448	0.00182	CcSEcCtD
Clonidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000447	0.00181	CcSEcCtD
Clonidine—Headache—Fludarabine—lymphatic system cancer	0.000447	0.00181	CcSEcCtD
Clonidine—Tachycardia—Carmustine—lymphatic system cancer	0.000446	0.00181	CcSEcCtD
Clonidine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000443	0.0018	CcSEcCtD
Clonidine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000443	0.0018	CcSEcCtD
Clonidine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000442	0.00179	CcSEcCtD
Clonidine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000439	0.00178	CcSEcCtD
Clonidine—Lethargy—Methotrexate—lymphatic system cancer	0.000439	0.00178	CcSEcCtD
Clonidine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000438	0.00178	CcSEcCtD
Clonidine—Oedema—Vincristine—lymphatic system cancer	0.000436	0.00177	CcSEcCtD
Clonidine—Anorexia—Carmustine—lymphatic system cancer	0.000436	0.00177	CcSEcCtD
Clonidine—Infection—Vincristine—lymphatic system cancer	0.000433	0.00176	CcSEcCtD
Clonidine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000431	0.00175	CcSEcCtD
Clonidine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000428	0.00174	CcSEcCtD
Clonidine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000428	0.00173	CcSEcCtD
Clonidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000427	0.00173	CcSEcCtD
Clonidine—Hypotension—Carmustine—lymphatic system cancer	0.000427	0.00173	CcSEcCtD
Clonidine—Oedema—Mitoxantrone—lymphatic system cancer	0.000425	0.00172	CcSEcCtD
Clonidine—Nausea—Fludarabine—lymphatic system cancer	0.000424	0.00172	CcSEcCtD
Clonidine—Infection—Mitoxantrone—lymphatic system cancer	0.000422	0.00171	CcSEcCtD
Clonidine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000422	0.00171	CcSEcCtD
Clonidine—Shock—Mitoxantrone—lymphatic system cancer	0.000418	0.00169	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000416	0.00169	CcSEcCtD
Clonidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000416	0.00169	CcSEcCtD
Clonidine—Urticaria—Bleomycin—lymphatic system cancer	0.000416	0.00169	CcSEcCtD
Clonidine—Anorexia—Vincristine—lymphatic system cancer	0.000416	0.00169	CcSEcCtD
Clonidine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000415	0.00168	CcSEcCtD
Clonidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000414	0.00168	CcSEcCtD
Clonidine—Insomnia—Carmustine—lymphatic system cancer	0.000413	0.00168	CcSEcCtD
Clonidine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000413	0.00167	CcSEcCtD
Clonidine—Irritability—Methotrexate—lymphatic system cancer	0.000411	0.00167	CcSEcCtD
Clonidine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000411	0.00167	CcSEcCtD
Clonidine—Paraesthesia—Carmustine—lymphatic system cancer	0.00041	0.00166	CcSEcCtD
Clonidine—Hypotension—Vincristine—lymphatic system cancer	0.000408	0.00165	CcSEcCtD
Clonidine—Dyspnoea—Carmustine—lymphatic system cancer	0.000407	0.00165	CcSEcCtD
Clonidine—Somnolence—Carmustine—lymphatic system cancer	0.000406	0.00165	CcSEcCtD
Clonidine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000405	0.00164	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000398	0.00161	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000397	0.00161	CcSEcCtD
Clonidine—Decreased appetite—Carmustine—lymphatic system cancer	0.000397	0.00161	CcSEcCtD
Clonidine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000397	0.00161	CcSEcCtD
Clonidine—Insomnia—Vincristine—lymphatic system cancer	0.000395	0.0016	CcSEcCtD
Clonidine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000395	0.0016	CcSEcCtD
Clonidine—Paraesthesia—Vincristine—lymphatic system cancer	0.000392	0.00159	CcSEcCtD
Clonidine—Constipation—Carmustine—lymphatic system cancer	0.000391	0.00158	CcSEcCtD
Clonidine—Pain—Carmustine—lymphatic system cancer	0.000391	0.00158	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—lymphatic system cancer	0.000389	0.00158	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000387	0.00157	CcSEcCtD
Clonidine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000386	0.00156	CcSEcCtD
Clonidine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000381	0.00155	CcSEcCtD
Clonidine—Decreased appetite—Vincristine—lymphatic system cancer	0.000379	0.00154	CcSEcCtD
Clonidine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000379	0.00154	CcSEcCtD
Clonidine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000378	0.00153	CcSEcCtD
Clonidine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000377	0.00153	CcSEcCtD
Clonidine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000377	0.00153	CcSEcCtD
Clonidine—Fatigue—Vincristine—lymphatic system cancer	0.000376	0.00152	CcSEcCtD
Clonidine—Asthenia—Bleomycin—lymphatic system cancer	0.000376	0.00152	CcSEcCtD
Clonidine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000374	0.00151	CcSEcCtD
Clonidine—Pain—Vincristine—lymphatic system cancer	0.000373	0.00151	CcSEcCtD
Clonidine—Constipation—Vincristine—lymphatic system cancer	0.000373	0.00151	CcSEcCtD
Clonidine—Asthma—Methotrexate—lymphatic system cancer	0.000372	0.00151	CcSEcCtD
Clonidine—Pruritus—Bleomycin—lymphatic system cancer	0.00037	0.0015	CcSEcCtD
Clonidine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000369	0.0015	CcSEcCtD
Clonidine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000366	0.00148	CcSEcCtD
Clonidine—Pain—Mitoxantrone—lymphatic system cancer	0.000363	0.00147	CcSEcCtD
Clonidine—Constipation—Mitoxantrone—lymphatic system cancer	0.000363	0.00147	CcSEcCtD
Clonidine—Abdominal pain—Carmustine—lymphatic system cancer	0.000361	0.00146	CcSEcCtD
Clonidine—Body temperature increased—Carmustine—lymphatic system cancer	0.000361	0.00146	CcSEcCtD
Clonidine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000357	0.00145	CcSEcCtD
Clonidine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00035	0.00142	CcSEcCtD
Clonidine—Dysuria—Methotrexate—lymphatic system cancer	0.000348	0.00141	CcSEcCtD
Clonidine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000347	0.00141	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000346	0.0014	CcSEcCtD
Clonidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000345	0.0014	CcSEcCtD
Clonidine—Abdominal pain—Vincristine—lymphatic system cancer	0.000345	0.0014	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000343	0.00139	CcSEcCtD
Clonidine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000337	0.00137	CcSEcCtD
Clonidine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000337	0.00136	CcSEcCtD
Clonidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000336	0.00136	CcSEcCtD
Clonidine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000336	0.00136	CcSEcCtD
Clonidine—Vomiting—Bleomycin—lymphatic system cancer	0.000333	0.00135	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—lymphatic system cancer	0.000332	0.00135	CcSEcCtD
Clonidine—Depression—Methotrexate—lymphatic system cancer	0.000331	0.00134	CcSEcCtD
Clonidine—Rash—Bleomycin—lymphatic system cancer	0.00033	0.00134	CcSEcCtD
Clonidine—Dermatitis—Bleomycin—lymphatic system cancer	0.00033	0.00134	CcSEcCtD
Clonidine—Asthenia—Carmustine—lymphatic system cancer	0.000328	0.00133	CcSEcCtD
Clonidine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000321	0.0013	CcSEcCtD
Clonidine—Sweating—Methotrexate—lymphatic system cancer	0.000318	0.00129	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—lymphatic system cancer	0.000313	0.00127	CcSEcCtD
Clonidine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000313	0.00127	CcSEcCtD
Clonidine—Asthenia—Vincristine—lymphatic system cancer	0.000313	0.00127	CcSEcCtD
Clonidine—Diarrhoea—Carmustine—lymphatic system cancer	0.000313	0.00127	CcSEcCtD
Clonidine—Nausea—Bleomycin—lymphatic system cancer	0.000311	0.00126	CcSEcCtD
Clonidine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000305	0.00124	CcSEcCtD
Clonidine—Dizziness—Carmustine—lymphatic system cancer	0.000302	0.00123	CcSEcCtD
Clonidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000298	0.00121	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—lymphatic system cancer	0.000298	0.00121	CcSEcCtD
Clonidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000291	0.00118	CcSEcCtD
Clonidine—Vomiting—Carmustine—lymphatic system cancer	0.000291	0.00118	CcSEcCtD
Clonidine—Dizziness—Vincristine—lymphatic system cancer	0.000288	0.00117	CcSEcCtD
Clonidine—Rash—Carmustine—lymphatic system cancer	0.000288	0.00117	CcSEcCtD
Clonidine—Dermatitis—Carmustine—lymphatic system cancer	0.000288	0.00117	CcSEcCtD
Clonidine—Headache—Carmustine—lymphatic system cancer	0.000286	0.00116	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—lymphatic system cancer	0.000278	0.00113	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—lymphatic system cancer	0.000278	0.00113	CcSEcCtD
Clonidine—Vomiting—Vincristine—lymphatic system cancer	0.000277	0.00112	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000276	0.00112	CcSEcCtD
Clonidine—Rash—Vincristine—lymphatic system cancer	0.000275	0.00112	CcSEcCtD
Clonidine—Dermatitis—Vincristine—lymphatic system cancer	0.000275	0.00111	CcSEcCtD
Clonidine—Headache—Vincristine—lymphatic system cancer	0.000273	0.00111	CcSEcCtD
Clonidine—Nausea—Carmustine—lymphatic system cancer	0.000271	0.0011	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—lymphatic system cancer	0.00027	0.0011	CcSEcCtD
Clonidine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00027	0.0011	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000269	0.00109	CcSEcCtD
Clonidine—Rash—Mitoxantrone—lymphatic system cancer	0.000268	0.00109	CcSEcCtD
Clonidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000268	0.00108	CcSEcCtD
Clonidine—Headache—Mitoxantrone—lymphatic system cancer	0.000266	0.00108	CcSEcCtD
Clonidine—Alopecia—Methotrexate—lymphatic system cancer	0.000263	0.00107	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—lymphatic system cancer	0.000261	0.00106	CcSEcCtD
Clonidine—Erythema—Methotrexate—lymphatic system cancer	0.000259	0.00105	CcSEcCtD
Clonidine—Nausea—Vincristine—lymphatic system cancer	0.000259	0.00105	CcSEcCtD
Clonidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000252	0.00102	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—lymphatic system cancer	0.000244	0.000991	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000241	0.000976	CcSEcCtD
Clonidine—Malaise—Methotrexate—lymphatic system cancer	0.000234	0.000948	CcSEcCtD
Clonidine—Cough—Methotrexate—lymphatic system cancer	0.000226	0.000918	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—lymphatic system cancer	0.000221	0.000895	CcSEcCtD
Clonidine—Chest pain—Methotrexate—lymphatic system cancer	0.000221	0.000895	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000219	0.000889	CcSEcCtD
Clonidine—Discomfort—Methotrexate—lymphatic system cancer	0.000218	0.000884	CcSEcCtD
Clonidine—Confusional state—Methotrexate—lymphatic system cancer	0.000213	0.000865	CcSEcCtD
Clonidine—Infection—Methotrexate—lymphatic system cancer	0.00021	0.000853	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000208	0.000842	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000207	0.00084	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—lymphatic system cancer	0.000206	0.000834	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000205	0.00083	CcSEcCtD
Clonidine—Anorexia—Methotrexate—lymphatic system cancer	0.000202	0.000818	CcSEcCtD
Clonidine—Hypotension—Methotrexate—lymphatic system cancer	0.000198	0.000802	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000193	0.000782	CcSEcCtD
Clonidine—Insomnia—Methotrexate—lymphatic system cancer	0.000191	0.000776	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00019	0.000771	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000189	0.000765	CcSEcCtD
Clonidine—Somnolence—Methotrexate—lymphatic system cancer	0.000188	0.000763	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000184	0.000746	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000183	0.000741	CcSEcCtD
Clonidine—Fatigue—Methotrexate—lymphatic system cancer	0.000182	0.00074	CcSEcCtD
Clonidine—Pain—Methotrexate—lymphatic system cancer	0.000181	0.000734	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000174	0.000707	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000173	0.000702	CcSEcCtD
Clonidine—Urticaria—Methotrexate—lymphatic system cancer	0.000168	0.000682	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000167	0.000678	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000167	0.000678	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000156	0.000632	CcSEcCtD
Clonidine—Asthenia—Methotrexate—lymphatic system cancer	0.000152	0.000616	CcSEcCtD
Clonidine—Pruritus—Methotrexate—lymphatic system cancer	0.00015	0.000607	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000145	0.000587	CcSEcCtD
Clonidine—Dizziness—Methotrexate—lymphatic system cancer	0.00014	0.000567	CcSEcCtD
Clonidine—Vomiting—Methotrexate—lymphatic system cancer	0.000135	0.000546	CcSEcCtD
Clonidine—Rash—Methotrexate—lymphatic system cancer	0.000133	0.000541	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000133	0.000541	CcSEcCtD
Clonidine—Headache—Methotrexate—lymphatic system cancer	0.000133	0.000538	CcSEcCtD
Clonidine—Nausea—Methotrexate—lymphatic system cancer	0.000126	0.00051	CcSEcCtD
